{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:25:46Z","timestamp":1790983546451,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T00:00:00Z","timestamp":1526947200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1038\/s41371-018-0069-7","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T08:41:32Z","timestamp":1526978492000},"page":"524-530","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Postmenopausal osteoporosis is associated with elevated aldosterone\/renin ratio"],"prefix":"10.1038","volume":"32","author":[{"name":"the Chongqing Primary Aldosteronism Study(CONPASS) Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Shu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linqiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfeng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianna","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7249-6445","authenticated-orcid":false,"given":"Qifu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,22]]},"reference":[{"key":"69_CR1","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","volume":"69","author":"S Monticone","year":"2017","unstructured":"Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, Buffolo F, et al. Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J Am Coll Cardiol. 2017;69:1811\u201320.","journal-title":"J Am Coll Cardiol"},{"key":"69_CR2","first-page":"2854","volume":"85","author":"KC Loh","year":"2000","unstructured":"Loh KC, Koay ES, Khaw MC, Emmanuel SC, Young WF Jr.. Prevalence of primary aldosteronism among asian hypertensive patients in singapore. J Clin Endocrinol Metab. 2000;85:2854\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"69_CR3","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1373\/clinchem.2015.242990","volume":"61","author":"JE Raizman","year":"2015","unstructured":"Raizman JE, Diamandis EP, Holmes D, Stowasser M, Auchus R, Cavalier E. A renin-ssance in primary aldosteronism testing: obstacles and opportunities for screening, diagnosis, and management. Clin Chem. 2015;61:1022\u20137.","journal-title":"Clin Chem"},{"key":"69_CR4","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1055\/s-0031-1295460","volume":"44","author":"M Stowasser","year":"2012","unstructured":"Stowasser M, Ahmed AH, Pimenta E, Taylor PJ, Gordon RD. Factors affecting the aldosterone\/renin ratio. Horm Metab Res. 2012;44:170\u20136.","journal-title":"Horm Metab Res"},{"key":"69_CR5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/HJH.0b013e32833266e3","volume":"28","author":"F Pizzolo","year":"2010","unstructured":"Pizzolo F, Raffaelli R, Memmo A, Chiecchi L, Pavan C, Guarini P, et al. Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism. J Hypertens. 2010;28:135\u201342.","journal-title":"J Hypertens"},{"key":"69_CR6","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1161\/01.HYP.0000258554.87444.91","volume":"49","author":"C Newton-Cheh","year":"2007","unstructured":"Newton-Cheh C, Guo CY, Gona P, Larson MG, Benjamin EJ, Wang TJ, et al. Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample. Hypertension. 2007;49:846\u201356.","journal-title":"Hypertension"},{"key":"69_CR7","doi-asserted-by":"publisher","first-page":"E340","DOI":"10.1210\/jc.2010-1355","volume":"96","author":"AH Ahmed","year":"2011","unstructured":"Ahmed AH, Gordon RD, Taylor PJ, Ward G, Pimenta E, Stowasser M. Are women more at risk of false-positive primary aldosteronism screening and unnecessary suppression testing than men? J Clin Endocrinol Metab. 2011;96:E340\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"69_CR8","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1038\/550S15a","volume":"550","author":"C Brown","year":"2017","unstructured":"Brown C. Osteoporosis: staying strong. Nature. 2017;550:S15\u20137.","journal-title":"Nature"},{"key":"69_CR9","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1007\/s00198-009-0925-y","volume":"20","author":"Y Wang","year":"2009","unstructured":"Wang Y, Tao Y, Hyman ME, Li J, Chen Y. Osteoporosis in China. Osteoporos Int. 2009;20:1651\u201362.","journal-title":"Osteoporos Int"},{"key":"69_CR10","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1161\/01.HYP.36.5.780","volume":"36","author":"S Wassertheil-Smoller","year":"2000","unstructured":"Wassertheil-Smoller S, Anderson G, Psaty BM, Black HR, Manson J, Wong N, et al. Hypertension and its treatment in postmenopausal women: baseline data from the women\u2019s health initiative. Hypertension. 2000;36:780\u20139.","journal-title":"Hypertension"},{"key":"69_CR11","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:1889\u2013916.","journal-title":"J Clin Endocrinol Metab"},{"key":"69_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/MED.0000000000000062","volume":"21","author":"JM Brown","year":"2014","unstructured":"Brown JM, Vaidya A. Interactions between adrenal-regulatory and calcium-regulatory hormones in human health. Curr Opin Endocrinol Diabetes Obes. 2014;21:193\u2013201.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"69_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.metabol.2013.08.016","volume":"63","author":"A Tomaschitz","year":"2014","unstructured":"Tomaschitz A, Ritz E, Pieske B, Rus-Machan J, Kienreich K, Verheyen N, et al. Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease. Metabolism. 2014;63:20\u201331.","journal-title":"Metabolism"},{"key":"69_CR14","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/jch.12825","volume":"18","author":"MR Grubler","year":"2016","unstructured":"Grubler MR, Gaksch M, Kienreich K, Verheyen N, Schmid J, OH BW, et al. Effects of vitamin d supplementation on plasma aldosterone and renin-a randomized placebo-controlled trial. J Clin Hypertens (Greenwich). 2016;18:608\u201313.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"69_CR15","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/jbmr.5650090802","volume":"9","author":"JA Kanis","year":"1994","unstructured":"Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res. 1994;9:1137\u201341.","journal-title":"J Bone Miner Res"},{"key":"69_CR16","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1210\/jc.2013-4440","volume":"99","author":"BZ Leder","year":"2014","unstructured":"Leder BZ, Tsai JN, Uihlein AV, Burnett-Bowie SA, Zhu Y, Foley K, et al. Two years of denosumab and teriparatide administration in postmenopausal women with osteoporosis (the data extension study): a randomized controlled trial. J Clin Endocrinol Metab. 2014;99:1694\u2013700.","journal-title":"J Clin Endocrinol Metab"},{"key":"69_CR17","first-page":"360","volume":"2","author":"HN Hulter","year":"1986","unstructured":"Hulter HN, Melby JC, Peterson JC, Cooke CR. Chronic continuous pth infusion results in hypertension in normal subjects. J Clin Hypertens. 1986;2:360\u201370.","journal-title":"J Clin Hypertens"},{"key":"69_CR18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1161\/HYPERTENSIONAHA.111.173948","volume":"58","author":"C Maniero","year":"2011","unstructured":"Maniero C, Fassina A, Guzzardo V, Lenzini L, Amadori G, Pelizzo MR, et al. Primary hyperparathyroidism with concurrent primary aldosteronism. Hypertension. 2011;58:341\u20136.","journal-title":"Hypertension"},{"key":"69_CR19","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/1097-0142(19910215)67:4<984::AID-CNCR2820670421>3.0.CO;2-0","volume":"67","author":"S Kitazawa","year":"1991","unstructured":"Kitazawa S, Fukase M, Kitazawa R, Takenaka A, Gotoh A, Fujita T, et al. Immunohistologic evaluation of parathyroid hormone-related protein in human lung cancer and normal tissue with newly developed monoclonal antibody. Cancer. 1991;67:984\u20139.","journal-title":"Cancer"},{"key":"69_CR20","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1210\/endo-129-1-489","volume":"129","author":"CM Isales","year":"1991","unstructured":"Isales CM, Barrett PQ, Brines M, Bollag W, Rasmussen H. Parathyroid hormone modulates angiotensin ii-induced aldosterone secretion from the adrenal glomerulosa cell. Endocrinology. 1991;129:489\u201395.","journal-title":"Endocrinology"},{"key":"69_CR21","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1210\/jc.2013-3214","volume":"99","author":"E Fischer","year":"2014","unstructured":"Fischer E, Hannemann A, Rettig R, Lieb W, Nauck M, Pallauf A, et al. A high aldosterone to renin ratio is associated with high serum parathyroid hormone concentrations in the general population. J Clin Endocrinol Metab. 2014;99:965\u201371.","journal-title":"J Clin Endocrinol Metab"},{"key":"69_CR22","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.surg.2009.09.041","volume":"146","author":"L Brunaud","year":"2009","unstructured":"Brunaud L, Germain A, Zarnegar R, Rancier M, Alrasheedi S, Caillard C, et al. Serum aldosterone is correlated positively to parathyroid hormone (pth) levels in patients with primary hyperparathyroidism. Surgery. 2009;146:1035\u201341.","journal-title":"Surgery"},{"key":"69_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1042\/cs0840011","volume":"84","author":"C Saussine","year":"1993","unstructured":"Saussine C, Judes C, Massfelder T, Musso MJ, Simeoni U, Hannedouche T, et al. Stimulatory action of parathyroid hormone on renin secretion in vitro: a study using isolated rat kidney, isolated rabbit glomeruli and superfused dispersed rat juxtaglomerular cells. Clin Sci (Lond). 1993;84:11\u20139.","journal-title":"Clin Sci (Lond)"},{"key":"69_CR24","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0026-0495(99)90075-6","volume":"48","author":"G Bernini","year":"1999","unstructured":"Bernini G, Moretti A, Lonzi S, Bendinelli C, Miccoli P, Salvetti A. Renin-angiotensin-aldosterone system in primary hyperparathyroidism before and after surgery. Metabolism. 1999;48:298\u2013300.","journal-title":"Metabolism"},{"key":"69_CR25","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1161\/HYPERTENSIONAHA.109.148619","volume":"55","author":"JP Forman","year":"2010","unstructured":"Forman JP, Williams JS, Fisher ND. Plasma 25-hydroxyvitamin d and regulation of the renin-angiotensin system in humans. Hypertension. 2010;55:1283\u20138.","journal-title":"Hypertension"},{"key":"69_CR26","doi-asserted-by":"publisher","first-page":"29821","DOI":"10.1074\/jbc.M705495200","volume":"282","author":"W Yuan","year":"2007","unstructured":"Yuan W, Pan W, Kong J, Zheng W, Szeto FL, Wong KE, et al. 1,25-dihydroxyvitamin d3 suppresses renin gene transcription by blocking the activity of the cyclic amp response element in the renin gene promoter. J Biol Chem. 2007;282:29821\u201330.","journal-title":"J Biol Chem"},{"key":"69_CR27","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1210\/jc.2012-1156","volume":"97","author":"A Vaidya","year":"2012","unstructured":"Vaidya A, Sun B, Larson C, Forman JP, Williams JS. Vitamin d3 therapy corrects the tissue sensitivity to angiotensin ii akin to the action of a converting enzyme inhibitor in obese hypertensives: an interventional study. J Clin Endocrinol Metab. 2012;97:2456\u201365.","journal-title":"J Clin Endocrinol Metab"},{"key":"69_CR28","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1172\/JCI117998","volume":"95","author":"K Prank","year":"1995","unstructured":"Prank K, Nowlan SJ, Harms HM, Kloppstech M, Brabant G, Hesch RD, et al. Time series prediction of plasma hormone concentration. Evidence for differences in predictability of parathyroid hormone secretion between osteoporotic patients and normal controls. J Clin Invest. 1995;95:2910\u20139.","journal-title":"J Clin Invest"},{"key":"69_CR29","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/jbmr.3033","volume":"32","author":"VC Wu","year":"2017","unstructured":"Wu VC, Chang CH, Wang CY, Lin YH, Kao TW, Lin PC, et al. Risk of fracture in primary aldosteronism: a population-based cohort study. J Bone Miner Res. 2017;32:743\u201352.","journal-title":"J Bone Miner Res"},{"key":"69_CR30","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1007\/s00198-013-2399-1","volume":"24","author":"L Ceccoli","year":"2013","unstructured":"Ceccoli L, Ronconi V, Giovannini L, Marcheggiani M, Turchi F, Boscaro M, et al. Bone health and aldosterone excess. Osteoporos Int. 2013;24:2801\u20137.","journal-title":"Osteoporos Int"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41371-018-0069-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41371-018-0069-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41371-018-0069-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:22:59Z","timestamp":1684617779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41371-018-0069-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,22]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["69"],"URL":"https:\/\/doi.org\/10.1038\/s41371-018-0069-7","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,22]]},"assertion":[{"value":"2 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}